Stocksigma LogoStocksigma Logo

SMS Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 31,609 (+30.4% YoY | +52.7% QoQ) ■ EBITDA: 6,766 (+39.9% YoY | +65.2% QoQ) ■ EBITDA Margin (%): 21.4 (+145 bps YoY | +162 bps QoQ) ■ PAT: 3,985

SMS Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

SMS Pharmaceuticals Ltd · Outcome · 04 Nov 2026, 6:56 pm

SMS Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 31,609 (+30.4% YoY | +52.7% QoQ) ■ EBITDA: 6,766 (+39.9% YoY | +65.2% QoQ) ■ EBITDA Margin (%): 21.4 (+145 bps YoY | +162 bps QoQ) ■ PAT: 3,985 (+57.4% YoY | +90.6% QoQ) ■ EPS (INR): 4.26 (+50.0% YoY | +91.0% QoQ)

Original exchange filing (PDF)

More announcements from SMS Pharmaceuticals Ltd

All SMS Pharmaceuticals Ltd announcements